SCHEMBL5322732

SCHEMBL5322732

CCO[Al]OCC.[HH].[HH].[LiH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2671575 0.92
Iodide SCHEMBL11348804 0.88
Lithium SCHEMBL7929038 0.88
SCHEMBL4046300 0.88
Hydrochloric Acid SCHEMBL1170290 0.88
Bromide SCHEMBL11354974 0.88
Lithium Ion SCHEMBL1408733 0.85
SCHEMBL827627 0.85
SCHEMBL27485439 0.81
SCHEMBL28321420 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633241-B2 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol Forest Laboratories Holdings, Limited (BM) 2014-01-21 US disclosed
US-20130296583-A1 Nebivolol and its Pharmaceutically Acceptable Salts, Process for Preparation and Pharmaceutical Compositions of Nebivolol FOREST LABORATORIES HOLDINGS UNLIMITED COMPANY (BM) 2013-11-07 US disclosed
US-20070259950-A1 Nebivolol and Its Pharmaceutically Acceptable Salts, Process for Preparation and Pharmaceutical Compositions of Nebivolol TORRENT PHARMACEUTICALS LIMITED (IN) 2007-11-08 US disclosed
EP-1741712-A2 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of Nebivolol Torrent Pharmaceuticals Ltd (IN) 2007-01-10 EP disclosed
EP-1737847-A2 NEBIVOLOL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS OF NEBIVOLOL Torrent Pharmaceuticals Ltd (IN) 2007-01-03 EP disclosed
WO-2006025070-A2 NEBIVOLOL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS OF NEBIVOLOL TORRENT PHARMACEUTICALS LIMITED (IN) 2006-03-09 WO disclosed